Doctor Explains Why Almost 75% of People Quit GLP-1s
Dr. Jones, DC — Doctor Explains Why Almost 75% of People Quit GLP-1s
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=3pyqJHI_ck8
What this video covers
Almost three out of four people who started GLP-1 have actually stopped within two years. That’s from a US health record study of more than 125,000 people. And most people, they hear that and they assume the same thing. But the people who stop leave through three very different exits.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Almost three out of four people who started GLP-1 have actually stopped within two years.
- That’s from a US health record study of more than 125,000 people.
- In the big semaglutide trials, stomach side effects climbed with the doses and they hit the hardest while the dose was actually increasing.
- And in that health record study, people who developed serious digestive problems were more likely to stop.
- Then, I stopped losing any weight at all." In that big health record study, the less weight that people lost, the more likely they were to stop.
- One large trial tested lowering the dose instead of stopping.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.